Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

1.87
Delayed Data
As of 4:00pm ET
 -0.04 / -2.09%
Today’s Change
1.71
Today|||52-Week Range
5.99
-16.26%
Year-to-Date
No recent news for CytRx Corp.

Today’s Trading

Previous close1.91
Today’s open1.88
Day’s range1.87 - 1.99
Volume252,009
Average volume (3 months)411,808
Market cap$52.8M
Data as of 4:00pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)+35.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+100.00%
P/E ratioNM
Price/Sales150.86
Price/Book1.64

Competitors

 Today’s
change
Today’s
% change
ADMAADMA Biologics Inc-0.03-1.15%
SRRASierra Oncology Inc+0.19+6.55%
CFRXContraFect Corp+0.03+3.26%
PFNXPfenex Inc-0.09-4.07%
Data as of 4:00pm ET, 12/12/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$200.0K
Annual profit (last year)-$50.8M
Net profit margin-25,385.61%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Steven A. Kriegsman
Chief Financial Officer &
Treasurer
John Y. Caloz
Corporate headquarters
Los Angeles, California

Forecasts